Skip to search formSkip to main contentSkip to account menu

satranidazole

Known as: 1-methanesulfonyl-3-(1-methyl-5-nitroimidazol-2-yl)-2-imidazolidinone, 2-Imidazolidinone, 1-(1-methyl-5-nitro-1H-imidazol-2-yl)-3-(methylsulfonyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An objective of periodontal treatment is to suppress or eliminate sub gingival periodontal pathogens. Local delivery devices for… 
2013
2013
Objective: The goal in using a local nonsurgical controlled intrapocket device for the delivery of an antimicrobial agent is the… 
2011
2011
The extended Hildebrand solubility parameter approach is used to estimate the solubility of satranidazole in binary solvent… 
2011
2011
In the present work, an attempt has been made to enhance solubility and dissolution of poorly water soluble drug, satranidazole… 
1993
1993
The pharmacokinetic properties of metronidazole and satranidazole were studied in the golden hamster (Mesocricetus auratus), at a… 
1992
1992
A large number of nitroimidazoles have been examined for in vitro activity against three anaerobes - Bacteroides fragilis (Bf), a… 
1991
1991
The development of an assay to measure the sensitivity of drugs against Blastocystis hominis using the incorporation of 3H… 
1986
1986
Satranidazole (CG-10213-Go), a novel nitroimidazole possessing a C-N linkage at C2 of the imidazole ring has been examined… 
Highly Cited
1986
Highly Cited
1986
The activities of 12 5-nitroimidazoles and ten other compounds have been compared against Giardia intestinalis stock BRIS/83/HEPU… 
1985
1985
Satranidazole, a 5-nitroimidazole derivative, was tested for its activity against reference strains and clinical isolates of…